Osmium compounds for reduction of adverse inflammation

摘要

Reduction of adverse inflammatory reaction to an implant or a transplant, or following trauma or infection, is achieved through catalysis of dismutation of the superoxide radical anion by an osmium containing compound. Treatment diseases caused by superoxide dismutase deficiency or mutation with superoxide radical anion dismutating osmium compounds or a carbonate radical anion decay catalyzing polymeric N-oxide is also disclosed.